BELOW SUPERNAV drop zone ⇩

Eli Lilly exec resigns after personal relationship that violated policy

FILE- In this April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly’s new COVID-19 treatment helped the drugmaker’s fourth-quarter profit surge even though U.S. regulators approved its use late in the quarter. (AP Photo/Darron Cummings, File)

MAIN AREA TOP drop zone ⇩

MAIN AREA TOP drop zone ⇩

INDIANAPOLIS (AP) — Eli Lilly has replaced its chief financial officer who resigned following an investigation into a personal relationship that violated company policy.

Josh Smiley, senior vice president and chief financial officer for Eli Lilly and Company, speaks during an interview in San Francisco, California, U.S. January 13, 2020. (REUTERS/Stephen Lam/File Photo)

Josh Smiley stepped down as senior vice president and chief financial officer and will leave the company, the drugmaker said Tuesday, after it learned of “allegations of an inappropriate personal relationship” between Smiley and an employee.

The independent investigation found “consensual though inappropriate personal communications” between Smiley and some employees and behavior that demonstrated poor judgment, according to the company.

Lilly said Smiley’s behavior wasn’t tied to business matters or financial controls or statements.

The Associated Press left a message seeking comment from Smiley with a Lilly representative.

Smiley, a long-time company employee, had served as chief financial officer since 2018. He received total compensation valued at about $7.3 million in 2019 as the company’s second-highest paid executive, according to a Securities and Exchange Commission filing.

The drugmaker named its chief financial officer for Lilly Research Laboratories, Anat Ashkenazi, to replace Smiley.

Ashkenazi joined Lilly in 2001. She has a bachelor’s degree in finance and economics from Hebrew University and a master of business administration from Tel Aviv University.

The Indianapolis company recently reported better-than-expected fourth-quarter earnings, with a COVID-19 treatment bringing in $850 million in U.S. sales in the last three months of 2020.

Shares of Eli Lilly and Co. slipped 1% at the start of trading Tuesday to $203.28.

Business

Copyright 2024 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed

Site Settings Survey

 

MAIN AREA MIDDLE drop zone ⇩

Trending on NewsNation

MAIN AREA BOTTOM drop zone ⇩

tt

KC Chiefs parade shooting: 1 dead, 21 shot including 9 kids | Morning in America

Witness of Chiefs parade shooting describes suspect | Banfield

Kansas City Chiefs parade shooting: Mom of 2 dead, over 20 shot | Banfield

WWE star Ashley Massaro 'threatened' by board to keep quiet about alleged rape: Friend | Banfield

Friend of WWE star: Ashley Massaro 'spent hours' sobbing after alleged rape | Banfield

Sunny

la

66°F Sunny Feels like 66°
Wind
4 mph SSW
Humidity
33%
Sunrise
Sunset

Tonight

Partly cloudy skies early will give way to cloudy skies late. Slight chance of a rain shower. Low 52F. Winds light and variable.
52°F Partly cloudy skies early will give way to cloudy skies late. Slight chance of a rain shower. Low 52F. Winds light and variable.
Wind
5 mph SW
Precip
15%
Sunset
Moon Phase
Waxing Gibbous